Publications
Partners
Cape Town – Ascendis Health [JSE:ASC] completed the 100% acquisition of specialist medical company Surgical Innovations after receiving competition commission approval, and of Atka Pharma.
These two targeted acquisitions follow on the listing of Ascendis on the main board of the JSE in the pharmaceutical sector in November last year.
"These two exciting acquisitions, are aligned to our clearly stated growth strategy, and brings our total investment in the last two years to over R1.5bn, delivering on our deliberate strategy of combining mature, well managed, resilient and complementary brands with exciting growth potential in South Africa, as well as globally,” said Group Chief Executive Karsten Wellner.
“Surgical Innovations compliments the Pharma-Med division alongside Pharma-Chem, and is a fast growing medical device distributor, specialising in state of the art high-tech surgical device needs of South African surgeons."
It employs more than 135 staff and has achieved compound annual growth in revenue of over 20% over the last three years.
The company holds international key agencies for surgical and other medical equipment on an exclusive basis, which further enhances the Company’s positioning to service hospitals and clinics.
Atka’s products are mainly marketed in retail pharmacy on recommendations from medical practitioners. Atka has been growing in excess of 50% per annum in the last three years.
These two targeted acquisitions follow on the listing of Ascendis on the main board of the JSE in the pharmaceutical sector in November last year.
"These two exciting acquisitions, are aligned to our clearly stated growth strategy, and brings our total investment in the last two years to over R1.5bn, delivering on our deliberate strategy of combining mature, well managed, resilient and complementary brands with exciting growth potential in South Africa, as well as globally,” said Group Chief Executive Karsten Wellner.
“Surgical Innovations compliments the Pharma-Med division alongside Pharma-Chem, and is a fast growing medical device distributor, specialising in state of the art high-tech surgical device needs of South African surgeons."
It employs more than 135 staff and has achieved compound annual growth in revenue of over 20% over the last three years.
The company holds international key agencies for surgical and other medical equipment on an exclusive basis, which further enhances the Company’s positioning to service hospitals and clinics.
Atka’s products are mainly marketed in retail pharmacy on recommendations from medical practitioners. Atka has been growing in excess of 50% per annum in the last three years.
